Skip to main content

Accessibility Tools

Share your perspective on current industry challenges in the Myonex 2026 Clinical Trial Supply Trends.

Carla Da Costa

Chief Operations Officer

Carla joined the Myonex Leadership Team during the integration of Creapharm and Myonex in 2024 and is responsible as COO for our global operations. Carla is a proven leader with more than 20 years of experience in services to the pharmaceutical industry, to both clinical and commercial-stage companies. Recently, she succeeded in different positions as Business Development Director and General Manager at Creapharm. Carla is a results-driven professional with strong analytical, managerial, and leadership skills. Her outstanding communication abilities allow her to engage effectively with all stakeholders, making her a key asset in steering operational success in a fast-paced, highly regulated environment. She graduated in commercial and marketing from ESCI and INSEAD Paris.